RecruitingPhase 4NCT06896617

Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)

Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET): a Prospective Randomized Controlled Study

Sponsor

Fundacion Clinic per a la Recerca Biomédica

Enrollment

334 participants

Start Date

Feb 1, 2025

Study Type

INTERVENTIONAL

Conditions

Embryo Transfer Infertilities

Summary

In pregnancies achieved through programmed frozen embryo transfer cycle (PC-FET) and modified natural frozen embryo transfer (mNC-FET), to determine whether there are differences in endothelial and placental function, maternal cardiovascular function, fetal growth and fetal cardiovascular and cerebral programming and to assess whether there is an association between these differences and the plasma concentrations of the main secretion products of the Corpus Luteum (CL) with vasoactive and angiogenic action.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 41 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Estradiol + Progesterone and a drug called Ovitrelle ( Hcg 250 mcg) for people with embryo transfer and infertilities. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 41 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.